Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business. Trinity Biotech's blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Diagnostic Substances
- Sub-Industry: N/A
- Symbol: NASDAQ:TRIB
- CUSIP: N/A
- Web: www.trinitybiotech.com
Capitalization:- Market Cap: $122.67 million
- Outstanding Shares: 22,102,000
Average Prices:- 50 Day Moving Avg: $5.52
- 200 Day Moving Avg: $6.21
- 52 Week Range: $5.20 - $13.68
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 12.91
- P/E Growth: 1.34
Sales & Book Value:- Annual Revenue: $99.63 million
- Price / Sales: 1.23
- Book Value: $4.94 per share
- Price / Book: 1.12
Profitability:- EBIDTA: $7.9 million
- Net Margins: 3.04%
- Return on Equity: 2.73%
- Return on Assets: 1.60%
Debt:- Debt-to-Equity Ratio: 0.48%
- Current Ratio: 7.27%
- Quick Ratio: 5.35%
Misc:- Average Volume: 56,245 shs.
- Beta: 1.17
- Short Ratio: 11.58
Frequently Asked Questions for Trinity Biotech plc (NASDAQ:TRIB)
What is Trinity Biotech plc's stock symbol?
Trinity Biotech plc trades on the NASDAQ under the ticker symbol "TRIB."
How were Trinity Biotech plc's earnings last quarter?
Trinity Biotech plc (NASDAQ:TRIB) issued its earnings results on Thursday, April, 27th. The company reported $0.01 EPS for the quarter, missing analysts' consensus estimates of $0.03 by $0.02. The firm earned $23.54 million during the quarter, compared to analysts' expectations of $24.24 million. Trinity Biotech plc had a net margin of 3.04% and a return on equity of 2.73%. View Trinity Biotech plc's Earnings History.
When will Trinity Biotech plc make its next earnings announcement?
Who are some of Trinity Biotech plc's key competitors?
Some companies that are related to Trinity Biotech plc include Cerus (CERS), Anavex Life Sciences Corp. (AVXL), Syndax Pharmaceuticals (SNDX), Voyager Therapeutics (VYGR), Idera Pharmaceuticals (IDRA), Tabula Rasa HealthCare (TRHC), Corvus Pharmaceuticals (CRVS), Miragen Therapeutics (MGEN), Aratana Therapeutics (PETX), Abeona Therapeutics (ABEO), Ardelyx (ARDX), Corindus Vascular Robotics (CVRS), BioScrip (BIOS), Chimerix (CMRX), Corium International (CORI), Cascadian Therapeutics (CASC), Immune Design Corp (IMDZ) and Cempra (CEMP).
Who owns Trinity Biotech plc stock?
Trinity Biotech plc's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Paradice Investment Management LLC (7.15%), Heartland Advisors Inc. (6.79%), Janus Capital Management LLC (6.42%), Boston Partners (5.75%), Lapides Asset Management LLC (5.81%) and
LAPIDES ASSET MANAGEMENT, LLC
(5.10%). View Institutional Ownership Trends for Trinity Biotech plc.
Who sold Trinity Biotech plc stock? Who is selling Trinity Biotech plc stock?
Trinity Biotech plc's stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Stonepine Capital Management LLC, Russell Investments Group Ltd., Geode Capital Management LLC, Oxford Asset Management, Benchmark Capital Advisors, JPMorgan Chase & Co. and Janus Capital Management LLC. View Insider Buying and Selling for Trinity Biotech plc.
Who bought Trinity Biotech plc stock? Who is buying Trinity Biotech plc stock?
Trinity Biotech plc's stock was purchased by a variety of institutional investors in the last quarter, including First Wilshire Securities Management Inc., Lapides Asset Management LLC, Teton Advisors Inc., Hunter Associates Investment Management LLC, Acadian Asset Management LLC, Nine Chapters Capital Management LLC, Renaissance Technologies LLC and Sawtooth Solutions LLC. View Insider Buying and Selling for Trinity Biotech plc.
How do I buy Trinity Biotech plc stock?
Shares of Trinity Biotech plc can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Trinity Biotech plc stock cost?
One share of Trinity Biotech plc stock can currently be purchased for approximately $5.55.
Earnings History for Trinity Biotech plc (NASDAQ:TRIB)Earnings History by Quarter for Trinity Biotech plc (NASDAQ:TRIB)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/19/2017 | | | | | | | | |
| 4/27/2017 | 3/31/2017 | $0.03 | $0.01 | $24.24 million | $23.54 million | View | N/A |  |
| 10/25/2016 | Q3 | $0.07 | $0.07 | $26.50 million | $26.10 million | View | Listen | |
| 7/21/2016 | Q2 | $0.06 | $0.09 | $24.30 million | $26.30 million | View | Listen | |
| 4/19/2016 | Q1 | $0.08 | $0.06 | $24.34 million | $23.52 million | View | Listen | |
| 3/3/2016 | Q4 | $0.09 | $0.29 | $251.00 million | $271.20 million | View | N/A | |
| 10/22/2015 | Q3 | $0.09 | $0.10 | $25.40 million | $27.20 million | View | Listen | |
| 7/28/2015 | Q2 | $0.14 | $0.07 | $26.09 million | $24.26 million | View | Listen | |
| 4/30/2015 | Q115 | $0.17 | $0.17 | $25.93 million | $25.20 million | View | N/A | |
| 3/3/2015 | Q414 | $0.18 | $0.18 | $27.30 million | $26.70 million | View | N/A | |
| 10/23/2014 | Q114 | $0.20 | $0.19 | $27.30 million | $27.20 million | View | Listen | |
| 7/29/2014 | Q413 | $0.20 | $0.18 | $27.00 million | $26.00 million | View | N/A | |
| 4/29/2014 | | $0.19 | $0.18 | $25.48 million | $25.03 million | View | N/A | |
| 3/4/2014 | Q4 | $0.21 | $0.20 | | | View | N/A | |
| 10/17/2013 | Q313 | $0.21 | $0.21 | $24.68 million | $24.10 million | View | N/A | |
| 7/30/2013 | Q2 2013 | $0.20 | $0.21 | $22.03 million | $21.30 million | View | N/A | |
| 3/5/2013 | Q4 2012 | $0.21 | $0.20 | $21.84 million | $20.80 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Trinity Biotech plc (NASDAQ:TRIB)2017 EPS Consensus Estimate: $0.26
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $0.04 | $0.04 | $0.04 |
| Q2 2017 | 1 | $0.06 | $0.06 | $0.06 |
| Q3 2017 | 1 | $0.08 | $0.08 | $0.08 |
| Q4 2017 | 1 | $0.08 | $0.08 | $0.08 |
(Data provided by Zacks Investment Research)
Dividend History by Quarter for Trinity Biotech plc (NASDAQ:TRIB)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 5/23/2014 | annual | $0.22 | 3.72% | 6/6/2014 | 6/10/2014 | 7/1/2014 |
(Data available from 1/1/2013 forward)
Insider Trading History for Trinity Biotech plc (NASDAQ:TRIB)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Trinity Biotech plc (NASDAQ:TRIB)
Latest Headlines for Trinity Biotech plc (NASDAQ:TRIB)
| Source: |
|
| Date | Headline |
|---|
 | Harwood Feffer LLP Announces Investigation of Trinity Biotech plc
finance.yahoo.com - May 22 at 7:18 PM |
 | Trinity Biotech plc (TRIB) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - May 17 at 8:58 AM |
| Trinity Biotech plc (TRIB) Cut to "Sell" at Zacks Investment Research
www.americanbankingnews.com - May 11 at 11:56 AM |
| Trinity Biotech Plc :TRIB-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017
finance.yahoo.com - May 3 at 10:12 AM |
| Trinity Biotech Plc :TRIB-US: Earnings Analysis: Q4, 2016 By the Numbers : May 1, 2017
finance.yahoo.com - May 1 at 7:26 PM |
| Edited Transcript of TRIB earnings conference call or presentation 27-Apr-17 3:00pm GMT
finance.yahoo.com - April 28 at 11:07 PM |
| Trinity Biotech plc (TRIB) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS
www.americanbankingnews.com - April 28 at 7:38 PM |
| Trinity Biotech plc (TRIB) Posts Quarterly Earnings Results, Misses Estimates By $0.02 EPS
www.americanbankingnews.com - April 28 at 4:50 PM |
| Somewhat Negative News Coverage Extremely Likely to Impact Trinity Biotech plc (TRIB) Stock Price
www.americanbankingnews.com - April 28 at 1:17 PM |
| Investor Network: Trinity Biotech Plc Sponsored ADR Class A to Host Earnings Call
finance.yahoo.com - April 27 at 9:54 PM |
| Trinity Biotech Announces Results for Q1, 2017
finance.yahoo.com - April 27 at 9:22 AM |
 | Form F-3/A TRINITY BIOTECH PLC
www.streetinsider.com - April 26 at 4:46 PM |
| Trinity Biotech plc (TRIB) Getting Positive News Coverage, AlphaOne Reports
www.americanbankingnews.com - April 19 at 8:23 AM |
 | Trinity Biotech plc to Announce First Quarter Fiscal Year 2017 Financial Results
feeds.benzinga.com - April 18 at 7:40 AM |
| Trinity Biotech plc (TRIB) Getting Favorable Media Coverage, AlphaOne Reports
www.americanbankingnews.com - April 15 at 12:57 PM |
| Trinity Biotech plc (TRIB) to Release Earnings on Monday
www.americanbankingnews.com - April 14 at 11:44 PM |
| Edited Transcript of TRIB earnings conference call or presentation 14-Mar-17 3:00pm GMT
finance.yahoo.com - March 15 at 12:52 AM |
 | BRIEF-Trinity Biotech quarterly EPS $0.043
www.reuters.com - March 14 at 7:50 PM |
| Trinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial Results
finance.yahoo.com - March 14 at 7:50 PM |
| Q4 2016 Trinity Biotech PLC Earnings Release - Time Not Supplied
biz.yahoo.com - March 14 at 8:56 AM |
| Trinity Biotech plc (TRIB) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - March 13 at 11:38 AM |
 | SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trinity Biotech plc (TRIB) - PR Newswire (press release)
www.prnewswire.com - March 2 at 12:05 AM |
| INVESTOR ALERT: Glancy Prongay & Murray Commences Investigation on Behalf of Trinity Biotech plc Investors
finance.yahoo.com - March 2 at 12:05 AM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Trinity Biotech plc (TRIB)
finance.yahoo.com - March 2 at 12:05 AM |
| Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2016 Financial Results
finance.yahoo.com - February 24 at 11:03 AM |
| Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2016 Financial Results
feeds.benzinga.com - February 24 at 8:13 AM |
 | Immunoassay Markets: Global Analysis and Opportunity Evaluation 2016 - 2020
www.marketwatch.com - January 24 at 12:17 AM |
| The Top 200 IVD Companies In Europe
finance.yahoo.com - January 16 at 8:05 PM |
 | Bragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages ... - Business Wire (press release)
www.businesswire.com - January 7 at 6:07 AM |
| Bragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages Investors to Contact the Firm
finance.yahoo.com - January 6 at 6:15 AM |
| Form 6-K TRINITY BIOTECH PLC For: Dec 01
www.streetinsider.com - December 19 at 8:54 AM |
Trinity Biotech plc (TRIB) Chart for Sunday, May, 28, 2017
